Martin P - Search Results

1

Hepatocellular carcinoma: the high-risk patient.

Nissen NN, Martin P. Nissen NN, et al. Among authors: martin p. J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S79-85. doi: 10.1097/00004836-200211002-00003. J Clin Gastroenterol. 2002. PMID: 12394210 Review.

2

Morbidity in live liver donors: standards-based adverse event reporting further refined.

Shackleton CR, Vierling JM, Nissen N, Martin P, Poordad F, Tran T, Colquhoun SD. Shackleton CR, et al. Among authors: martin p. Arch Surg. 2005 Sep;140(9):888-95; discussion 895-6. doi: 10.1001/archsurg.140.9.888. Arch Surg. 2005. PMID: 16172298

3

Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.

Tran TT, Changsri C, Shackleton CR, Poordad FF, Nissen NN, Colquhoun S, Geller SA, Vierling JM, Martin P. Tran TT, et al. Among authors: martin p. J Gastroenterol Hepatol. 2006 Feb;21(2):381-3. doi: 10.1111/j.1440-1746.2005.03968.x. J Gastroenterol Hepatol. 2006. PMID: 16509862

4

Advances in liver transplantation. New strategies and current care expand access, enhance survival.

Tran TT, Nissen N, Poordad FF, Martin P. Tran TT, et al. Among authors: martin p. Postgrad Med. 2004 May;115(5):73-6, 79-85. doi: 10.3810/pgm.2004.05.1514. Postgrad Med. 2004. PMID: 15171080 Review.

5

Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.

Firpi RJ, Tran TT, Flores P, Nissen N, Colquhoun S, Shackleton C, Martin P, Vierling JM, Poordad FF. Firpi RJ, et al. Among authors: martin p. Aliment Pharmacol Ther. 2004 May 1;19(9):1033-9. doi: 10.1111/j.1365-2036.2004.01923.x. Aliment Pharmacol Ther. 2004. PMID: 15113371 Free article. Review.

6

Emerging drugs for the treatment of hepatocellular carcinoma.

Ayoub WS, Jones PD, Yang JD, Martin P. Ayoub WS, et al. Among authors: martin p. Expert Opin Emerg Drugs. 2022 Jun;27(2):141-149. doi: 10.1080/14728214.2022.2083107. Epub 2022 Jun 1. Expert Opin Emerg Drugs. 2022. PMID: 35642526

7

Conditions associated with hepatocellular carcinoma.

Lisker-Melman M, Martin P, Hoofnagle JH. Lisker-Melman M, et al. Among authors: martin p. Med Clin North Am. 1989 Jul;73(4):999-1009. doi: 10.1016/s0025-7125(16)30650-2. Med Clin North Am. 1989. PMID: 2542707 Review.

8

Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization.

Ly D, Yee HF Jr, Brezina M, Martin P, Gitnick G, Saab S. Ly D, et al. Among authors: martin p. Am J Gastroenterol. 2002 Jan;97(1):138-41. doi: 10.1111/j.1572-0241.2002.05437.x. Am J Gastroenterol. 2002. PMID: 11808938

9

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network. Di Bisceglie AM, et al. Among authors: martin p. Am J Gastroenterol. 2003 Sep;98(9):2060-3. doi: 10.1111/j.1572-0241.2003.t01-1-07641.x. Am J Gastroenterol. 2003. PMID: 14499788

10

Primary lymphoma of the liver in a patient with acquired immune deficiency syndrome and chronic hepatitis B.

Lisker-Melman M, Pittaluga S, Pluda JM, Kleiner DE, Thompson P, Martin P, Yarchoan R, Di Bisceglie AM. Lisker-Melman M, et al. Among authors: martin p. Am J Gastroenterol. 1989 Nov;84(11):1445-8. Am J Gastroenterol. 1989. PMID: 2683745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,895 results

Search Page